The study of global top 10 medical devices market is important mainly due to continuous technological advancements in the medical devices industry and rising demand for medical devices owing to increasing healthcare issues. This report not only provides a full estimate of the global top 10 medical device technologies market but also gives a detailed analysis of their most critical micro-markets, which have remained unexplored so far. The medical devices market is a major contributor to the overall healthcare industry with the pharmaceuticals industry leading the healthcare sector. The rising incidence of various diseases in the areas of Cardiovascular devices (CVD), respiratory, oncology, neurology, and many others have expanded the need for faster and better medical devices for treatment and diagnosis.

The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry

Scope of the report

This research report includes following segments:

• Cardiovascular devices
• Orthopedics devices
• Diagnostic imaging devices
• Minimally invasive devices
• Dtabetes devices
• Anesthesia and respiratory care devices
• Dialysis products
• Ophthalmology devices
• Patient monitoring devices
• Point-of-care diagnostic devices

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report provides more than 30 company profiles covering all the sub-segments.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

TABLE OF CONTENTS

EXECUTIVE SUMMARY        
    OBJECTIVE    
    MARKET SCENARIO    

1    INTRODUCTION    
1.1    KEY TAKE-AWAYS    
1.2    REPORT DESCRIPTION    
1.3    MARKETS COVERED    
1.4    STAKEHOLDERS    
1.5    RESEARCH METHODOLOGY    

2    SUMMARY    

3    MARKET OVERVIEW    
3.1    INTRODUCTION    
3.2    DEFINITION OF TOP 10 MEDICAL DEVICES MARKET    
3.3    DRIVERS    
3.3.1    AGING POPULATION IS A MAJOR GROWTH FACTOR    
3.3.2    ACCEPTANCE OF NEWER TECHNOLOGIES BY THE PHYSICIANS    
3.3.3    OUTSOURCING OF MEDICAL EQUIPMENT    
3.4    RESTRAINTS    
3.4.1    U.S. HEALTHCARE REFORM IMPACTING  THE MEDICAL DEVICE COMPANIES    
3.4.1.1    Excise tax    
3.4.1.2    Reduction in hospital orders    
3.5    OPPORTUNITIES    
3.5.1    RAPID GROWTH IN EMERGING MARKETS    
3.5.2    SECTORAL GROWTH IS EXPECTED POST IMPLEMENTATION OF REFORMS    
3.6    MEDICAL DEVICES MARKET SHARE    
3.7    MARKET DOMINANCE OF U.S. MANUFACTURERS    
3.8    HIGHER VISIBILITY OF CORE MEDICAL DEVICES COMPANIES    
3.9    CARDIOVASCULAR & ORTHOPEDICS DEVICES LEADING THE MARKET    
3.1    PATENT ANALYSIS    
3.10.1    DEVICE MANUFACTURERS FOCUSING ON RESPIRATORY DEVICES & PATIENT MONITORING    
3.10.2    KEY INDUSTRIAL PARTICIPANTS FOCUSING ON IMAGING AND DIALYSIS    

4    DIAGNOSTIC IMAGING    
4.1    INTRODUCTION    
4.2    DRIVERS    
4.2.1    NEW TECHNOLOGIES FOR DIAGNOSTIC IMAGING ENHANCE THE MARKET GROWTH    
4.2.2    EXPANDING APPLICATIONS FOR DIAGNOSTIC IMAGING    
4.3    BURNING ISSUES    
4.3.1    FDA INTERVENTION IN MEDICAL IMAGING TESTS    
4.4    MARKET SHARE    
4.5    ULTRASOUND    
4.5.1    DRIVERS    
4.5.1.1    Demand from emerging markets drives the ultrasound devices growth    
4.5.1.2    Increasing use of ultrasound equipment by  non-radiologists & for emergency medicine    
4.5.2    APPLICATION AREAS FOR ULTRASOUND IMAGING    
4.5.3    MARKET SHARE    
4.6    X-RAY    
4.6.1    DRIVERS    
4.6.1.1    Digital radiography boosts the overall X-ray equipment market    
4.6.1.2    Mammography diagnosis supports the X-ray equipment growth    
4.7    NUCLEAR IMAGING    
4.8    MRI    
4.9    COMPUTED TOMOGRAPHY (CT)    

5    CARDIOVASCULAR DEVICES    
5.1    INTRODUCTION    
5.2    DRIVERS & RESTRAINTS    
5.2.1    DEMOGRAPHIC FACTORS PROPELLING THE GROWTH    
5.2.2    NEW TECHNOLOGIES TAKING THE MARKET AHEAD    
5.2.3    HIGH DEGREE OF COMPETITION    
5.3    BURNING ISSUE    
5.3.1    ECG ON A MOVE    
5.4    CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES    
5.5    CARDIAC RHYTHM MANAGEMENT DEVICES    
5.6    INTERVENTION CARDIOLOGY    
5.7    PERIPHERAL VASCULAR DEVICES    
5.8    PROSTHETIC DEVICES    
5.9    CARDIAC SURGERY DEVICES    
5.10    ELECTROPHYSIOLOGY    

6    PATIENT MONITORING DEVICES    
6.1    INTRODUCTION    
6.2    DRIVERS & RESTRAINTS    
6.2.1    TECHNOLOGICAL ADVANCES FUELING THE GROWTH    
6.2.2    EMERGING MARKETS DRIVING THE GROWTH    
6.2.3    LOW COST MANUFACTURERS    
6.3    WINNING IMPERATIVE    
6.3.1    WIRELESS TECHNOLOGY DIFFERENTIATING THE PLAYERS    
6.4    PATIENT MONITORS    
6.5    VITAL SIGN MONITORS    
6.6    FETAL & NEONATAL MONITORS    
6.7    ANESTHESIA MONITORS    

7    OPHTHALMOLOGY DEVICES    
7.1    INTRODUCTION    
7.2    DRIVERS    
7.2.1    INCREASING INCIDENCE OF OPHTHALMOLOGY DISEASES    
7.2.2    TECHNOLOGICAL ADVANCES DRIVING THE MARKET    
7.3    RESTRAINTS    
7.3.1    HIGH COST OF TREATMENT    
7.3.2    LACK OF REIMBURSEMENT FOR LASER PROCEDURES    
7.4    WINNING IMPERATIVES    
7.4.1    POSITIONING THE PRODUCT PROPERLY GIVES A COMPETITIVE EDGE    
7.5    CATARACT DEVICES    
7.5.1    INTRAOCULAR LENS    
7.5.2    PHACOEMULSIFICATION EQUIPMENT & VISCOELASTIC DEVICES    
7.6    REFRACTIVE ERROR    
7.6.1    CONTACT LENS    
7.6.2    EXCIMER LASER    

8    MINIMALLY INVASIVE SURGICAL DEVICES,  BY SURGERY    
8.1    INTRODUCTION    
8.2    DRIVERS & RESTRAINTS    
8.2.1    MANY ADVANTAGES OF NON-INVASIVE SURGERY    
8.2.2    HIGH INITIAL COST    
8.2.3    RESTRICTED PATIENT APPLICABILITY    
8.3    TRENDS    
8.3.1    INCREASING USE OF SHAPE MEMORY ALLOY    
8.4    WINNING IMPERATIVES    
8.4.1    INNOVATION IS THE KEY TO SUCCESS    
8.5    CARDIOTHORACIC SURGERY    
8.6    ORTHOPEDIC SURGERY    
8.7    GASTROINTESTINAL SURGERY    
8.8    GYNECOLOGY SURGERY    

9    KIDNEY/DIALYSIS DEVICES    
9.1    INTRODUCTION    
9.2    DRIVERS    
9.2.1    INCREASE IN THE CASES OF CHRONIC KIDNEY DISEASES    
9.2.2    LESS NUMBER OF DONORS FOR RENAL TRANSPLANTS    
9.3    RESTRAINTS    
9.3.1    LOW PENETRATION IN DEVELOPING MARKET    
9.3.2    MARKET DOMINATED BY FEW LARGE PLAYERS    
9.4    WINNING IMPERATIVE    
9.4.1    INTEGRATION HELPS IN CUTTING DOWN THE COST    
9.5    HEMODIALYSIS PRODUCTS    
9.6    PERITONEAL DIALYSIS PRODUCTS    

10    POINT-OF-CARE DIAGNOSTIC DEVICES    
10.1    INTRODUCTION    
10.2    DRIVERS & RESTRAINTS    
10.2.1    SELF TESTING GIVING THE MOMENTUM    
10.2.2    MANY ADVANTAGES OF POINT-OF-CARE TESTING    
10.2.3    HIGHLY FRAGMENTED INDUSTRY    
10.3    BLOOD GLUCOSE MONITORING    
10.4    BLOOD CHEMISTRY & ELECTROLYTE    
10.5    PREGNANCY/FERTILITY    
10.6    CARDIOLOGY    
10.7    DRUG OF ABUSE MEASURING DEVICES    
10.8    INFECTIOUS DISEASES    

11    ANESTHESIA & RESPIRATORY CARE DEVICES    
11.1    INTRODUCTION    
11.2    DRIVERS & RESTRAINTS    
11.2.1    TECHNOLOGY ADVANCEMENTS    
11.2.2    COMPETITIVE PRICING BY OEMS    
11.3    OPPORTUNITIES    
11.3.1    MEDICAL TOURISM    
11.4    BURNING ISSUES    
11.4.1    U.S. HEALTH REFORMS TO IMPACT THE MARKET FOR ANESTHESIA & RESPIRATORY DEVICES    
11.4.2    INFORMATION TECHNOLOGY IN RESPIRATORY & ANESTHESIA DEVICES    
11.5    ANESTHESIA DEVICES    
11.5.1    ANESTHESIA MACHINES    
11.5.1.1    Workstations    
11.5.1.2    Delivery machines    
11.5.1.3    Ventilators    
11.5.1.4    Monitors    
11.5.2    ANESTHESIA DISPOSABLES    
11.5.2.1    Endotracheal tubes    
11.5.2.2    Anesthesia gas masks    
11.5.2.3    Anesthesia breathing circuits    
11.6    RESPIRATORY CARE DEVICES    
11.6.1    DRIVERS    
11.6.1.1    High prevalence of respiratory diseases    
11.6.1.2    Changing lifestyle & increasing number of smokers    
11.6.1.3    Growing number of aged people    
11.6.1.4    Technological advancements    
11.6.2    RESTRAINTS    
11.6.2.1    Economic slowdown    
11.6.3    KEY TRENDS    
11.6.3.1    Emerging economies demand cost-efficient equipment    
11.6.3.2    More focus on compact devices for diagnostics    
11.6.4    RESPIRATORY CARE THERAPEUTICS DEVICES    
11.6.4.1    Drivers    
11.6.4.1.1    Home healthcare growth has led to increased demand for therapeutic devices    
11.6.4.1.2    User-friendly systems & technology increases the adoption of devices    
11.6.4.2    Restraints    
11.6.4.2.1    Market saturation    
11.6.4.2.2    High cost of ownership restricts the adoption of devices    
11.6.4.3    Opportunities    
11.6.4.3.1    Used in delivery of Vaccines, Systemic Therapy & Gene-replacement Therapy    
11.6.4.4    Burning issues    
11.6.4.4.1    Ban on chlorofluorocarbon based Propellants    
11.6.4.4.2    Reduction in the reimbursement amount for Home Oxygen    
11.6.4.5    Winning imperatives    
11.6.4.5.1    Lower operating costs & packaging give a long-term advantage    
11.6.4.5.2    Portability is a key distinguishing feature    
11.6.4.6    Humidifiers    
11.6.4.6.1    Heated Humidifiers    
11.6.4.6.2    Passover Humidifiers    
11.6.4.7    Further classification of heated & passover humidifiers    
11.6.4.7.1    Integrated humidifiers    
11.6.4.7.2    Built-in humidifiers    
11.6.4.7.3    Stand alone humidifiers    
11.6.4.8    Nebulizers    
11.6.4.8.1    Compressor-based Nebulizers    
11.6.4.8.2    Piston-based hand held nebulizers    
11.6.4.8.3    Ultrasonic nebulizers    
11.6.4.9    Oxygen concentrators    
11.6.4.9.1    Fixed oxygen concentrators    
11.6.4.9.2    Portable oxygen concentrators    
11.6.4.10    Positive Airway Pressure (PAP) devices    
11.6.4.10.1    Continuous Positive Airway Pressure (CPAP) devices    
11.6.4.10.2    Other PAP devices market    
11.6.4.11    Reusable resuscitators    
11.6.4.12    Ventilators    
11.6.4.12.1    Adult Ventilators    
11.6.4.12.2    Neonatal Ventilators    
11.6.4.13    Respiratory inhalers    
11.6.4.13.1    Dry Powder Inhaler (DPI)    
11.6.4.13.2    Metered dose inhaler    
11.6.5    RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES    
11.6.5.1    Drivers & restraints    
11.6.5.1.1    Rising importance of monitoring respiratory diseases    
11.6.5.1.2    High level of saturation in pulse oximeter    
11.6.5.2    Burning issues    
11.6.5.2.1    WHO initiation for developing cost effective oximeters    
11.6.5.3    Winning imperatives    
11.6.5.3.1    Pulse oximeter market players focusing on additional features to gain competitive edge    
11.6.5.3.2    Compactness of devices as a unique selling proposition    
11.6.5.4    Respiratory care monitoring devices    
11.6.5.4.1    Pulse oximeter    
11.6.5.4.1.1    Pulse oximeter equipment    
11.6.5.4.1.2    Handheld pulse oximeters    
11.6.5.4.1.3    Fingertip pulse oximeters    
11.6.5.4.1.4    Tabletop pulse oximeters    
11.6.5.4.1.5    Wrist worn pulse oximeters    
11.6.5.4.1.6    Pulse oximeter sensors    
11.6.5.4.2    Capnographs    
11.6.5.4.3    Gas analyzers    
11.6.5.5    Respiratory disposables    
11.6.5.5.1    Oxygen mask    
11.6.5.5.2    Resuscitators    
11.6.5.5.3    Tracheostomy tubes    
11.6.5.5.4    Oxygen Cannulae    
11.6.6    RESPIRATORY CARE DIAGNOSTIC DEVICES (RESPIRATORY MEASUREMENT DEVICES)    
11.6.6.1    Drivers & Restraints    
11.6.6.1.1    Developing economies emerging as fast growth markets for diagnostic technologist    
11.6.6.1.2    Complicated Reimbursements process in diagnostic segment    
11.6.6.1.3    Highly competitive    
11.6.6.2    Opportunities    
11.6.6.2.1    Point-of-care diagnostics an upcoming opportunity    
11.6.6.3    Burning issues & trends    
11.6.6.3.1    Spirometry in Toddlers/Infants a challenge    
11.6.6.3.2    Spirometer on iphone    
11.6.6.4    Winning imperatives    
11.6.6.4.1    Focus on accurate & clinically important information    
11.6.6.5    Spirometer    
11.6.6.5.1    Mechanical volume spirometers    
11.6.6.5.2    Automated flow spirometers    
11.6.6.6    Peak flow meters    
11.6.6.7    Recorders/polysomnography devices    
11.6.6.8    Other diagnostic devices    
11.6.6.8.1    Exercise testing equipment    
11.6.6.8.2    Pneumotachometer    
11.6.6.8.2.1    Fleisch type pneumotachometer    
11.6.6.8.2.2    Lilly type pneumotachometer    
11.6.6.8.3    Plethysmograph    

12    DIABETES CARE DEVICES    
12.1    INTRODUCTION    
12.2    DRIVERS    
12.2.1    INCREASING OBESITY    
12.2.2    DEVELOPING ECONOMIES ARE PANDEMIC CENTERS OF DIABETES    
12.3    RESTRAINTS    
12.3.1    AFFORDABILITY LIMITS THE GROWTH IN DEVELOPING COUNTRIES    
12.3.2    RIGID MIND SET OF HEALTHCARE PROVIDERS    
12.4    WINNING IMPERATIVES    
12.4.1    KEY OPINION LEADERS HOLD THE KEY    
12.4.2    DISTRIBUTION IS THE BACKBONE TO SUCCESS    
12.5    TRENDS    
12.5.1    COMBINATION OF FUNCTIONS    
12.5.2    DIABETES VACCINE & INHALABLE INSULIN    
12.6    GLUCOSE MONITORING DEVICES    
12.6.1    BLOOD GLUCOSE TEST STRIPS    
12.6.2    BLOOD GLUCOSE METERS & LANCETS    
12.7    INSULIN DELIVERY DEVICES    

13    ORTHOPEDICS DEVICES    
13.1    INTRODUCTION    
13.2    DRIVERS    
13.2.1    ORTHOBIOLOGICS DRIVING THE INDUSTRY    
13.2.2    INCREASING REQUIREMENTS OF ORTHOPEDIC TRANSPLANTS    
13.3    RESTRAINTS    
13.3.1    FEW MAJOR MARKET PLAYERS    
13.3.2    ECONOMIC SLOWDOWN    
13.4    ORTHOBIOLOGICS    
13.5    JOINT RECONSTRUCTION    
13.6    SPINAL SURGERY DEVICES    
13.7    TRAUMA FIXATION PRODUCTS    
13.8    ARTHROSCOPIC DEVICES    
13.9    ORTHOPEDIC ACCESSORIES    
13.1    ORTHOPEDIC BRACES & SUPPORTS    

14    GEOGRAPHIC ANALYSIS    
14.1    INTRODUCTION    
14.2    NORTH AMERICA    
14.3    EUROPE    
14.4    ASIA    
14.5    ROW    

15    COMPETITIVE LANDSCAPE    
15.1    INTRODUCTION    

16    COMPANY PROFILES    
16.1    3M COMPANY    
16.1.1    OVERVIEW    
16.1.2    PRODUCTS & SERVICES    
16.1.3    FINANCIALS    
16.1.4    STRATEGY    
16.1.5    DEVELOPMENTS    
16.2    ABBOTT LABORATORIES    
16.2.1    OVERVIEW    
16.2.2    PRODUCTS & SERVICES    
16.2.3    FINANCIALS    
16.2.4    STRATEGY    
16.2.5    DEVELOPMENTS    
16.3    AGFA HEALTHCARE    
16.3.1    OVERVIEW    
16.3.2    PRODUCTS & SERVICES    
16.3.3    STRATEGY    
16.3.4    DEVELOPMENTS    
16.4    ALCON    
16.4.1    OVERVIEW    
16.4.2    PRODUCTS & SERVICES    
16.4.3    FINANCIALS    
16.4.4    STRATEGY    
16.4.5    DEVELOPMENTS    
16.5    ALLERGAN INC.    
16.5.1    OVERVIEW    
16.5.2    PRODUCTS & SERVICES    
16.5.3    FINANCIALS    
16.5.4    STRATEGY    
16.5.5    DEVELOPMENTS    
16.6    B. BRAUN    
16.6.1    OVERVIEW    
16.6.2    PRODUCTS & SERVICES    
16.6.3    FINANCIALS    
16.6.4    STRATEGY    
16.6.5    DEVELOPMENTS    
16.7    BAXTER INTERNATIONAL    
16.7.1    OVERVIEW    
16.7.2    PRODUCTS & SERVICES    
16.7.3    FINANCIALS    
16.7.4    STRATEGY    
16.7.5    DEVELOPMENTS    
16.8    BECKMAN COULTER    
16.8.1    OVERVIEW    
16.8.2    PRODUCTS & SERVICES    
16.8.3    FINANCIALS    
16.8.4    STRATEGY    
16.8.5    DEVELOPMENTS    
16.9    BECTON DICKINSON    
16.9.1    OVERVIEW    
16.9.2    PRODUCTS & SERVICES    
16.9.3    FINANCIALS    
16.9.4    STRATEGY    
16.9.5    DEVELOPMENTS    
16.10    BIOMET    
16.10.1    OVERVIEW    
16.10.2    PRODUCTS & SERVICES    
16.10.3    FINANCIALS    
16.10.4    STRATEGY    
16.10.5    DEVELOPMENTS    
16.11    BOSTON SCIENTIFIC CORPORATION    
16.11.1    OVERVIEW    
16.11.2    PRODUCTS & SERVICES    
16.11.3    FINANCIALS    
16.11.4    STRATEGY    
16.11.5    DEVELOPMENTS    
16.12    C.R. BARD    
16.12.1    OVERVIEW    
16.12.2    PRODUCTS & SERVICES    
16.12.3    FINANCIALS    
16.12.4    STRATEGY    
16.12.5    DEVELOPMENTS    
16.13    CARDINAL HEALTH    
16.13.1    OVERVIEW    
16.13.2    PRODUCTS & SERVICES    
16.13.3    FINANCIALS    
16.13.4    STRATEGY    
16.13.5    DEVELOPMENTS    
16.14    COVIDIEN    
16.14.1    OVERVIEW    
16.14.2    PRODUCTS & SERVICES    
16.14.3    FINANCIALS    
16.14.4    STRATEGY    
16.14.5    DEVELOPMENTS    
16.15    DANAHER    
16.15.1    OVERVIEW    
16.15.2    PRODUCTS & SERVICES    
16.15.3    FINANCIALS    
16.15.4    STRATEGY    
16.15.5    DEVELOPMENTS    
16.16    DENTSPLY INTERNATIONAL    
16.16.1    OVERVIEW    
16.16.2    PRODUCTS & SERVICES    
16.16.3    FINANCIALS    
16.16.4    STRATEGY    
16.16.5    DEVELOPMENTS    
16.17    FRESENIUS MEDICAL CARE    
16.17.1    OVERVIEW    
16.17.2    PRODUCTS & SERVICES    
16.17.3    FINANCIALS    
16.17.4    STRATEGY    
16.17.5    DEVELOPMENTS    
16.18    GE HEALTHCARE    
16.18.1    OVERVIEW    
16.18.2    PRODUCTS & SERVICES    
16.18.3    STRATEGY    
16.18.4    DEVELOPMENTS    
16.19    HITACHI MEDICAL CORPORATION    
16.19.1    OVERVIEW    
16.19.2    PRODUCTS & SERVICES    
16.19.3    FINANCIALS    
16.19.4    STRATEGY    
16.19.5    DEVELOPMENTS    
16.20    HOSPIRA    
16.20.1    OVERVIEW    
16.20.2    PRODUCTS & SERVICES    
16.20.3    FINANCIALS    
16.20.4    STRATEGY    
16.20.5    DEVELOPMENTS    
16.21    JOHNSON & JOHNSON    
16.21.1    OVERVIEW    
16.21.2    PRODUCTS & SERVICES    
16.21.3    FINANCIALS    
16.21.4    STRATEGY    
16.21.5    DEVELOPMENTS    
16.22    MEDTRONIC INC.    
16.22.1    OVERVIEW    
16.22.2    PRODUCTS & SERVICES    
16.22.3    FINANCIALS    
16.22.4    STRATEGY    
16.22.5    DEVELOPMENTS             
16.23    OLYMPUS CORPORATION    
16.23.1    OVERVIEW    
16.23.2    PRODUCTS & SERVICES    
16.23.3    FINANCIALS    
16.23.4    STRATEGY    
16.24    PHILIPS HEALTHCARE    
16.24.1    OVERVIEW    
16.24.2    PRODUCTS & SERVICES    
16.24.3    FINANCIALS    
16.24.4    STRATEGY    
16.24.5    DEVELOPMENTS    
16.25    SIEMENS HEALTHCARE    
16.25.1    OVERVIEW    
16.25.2    PRODUCTS & SERVICES    
16.25.3    STRATEGY    
16.25.4    DEVELOPMENTS    
16.26    SMITH & NEPHEW    
16.26.1    OVERVIEW    
16.26.2    PRODUCTS & SERVICES    
16.26.3    FINANCIALS    
16.26.4    STRATEGY    
16.26.5    DEVELOPMENTS    
16.27    ST. JUDE MEDICAL INC.    
16.27.1    OVERVIEW    
16.27.2    PRODUCTS & SERVICES    
16.27.3    FINANCIALS    
16.27.4    STRATEGY    
16.27.5    DEVELOPMENTS    
16.28    STRYKER    
16.28.1    OVERVIEW    
16.28.2    PRODUCTS & SERVICES    
16.28.3    FINANCIALS    
16.28.4    STRATEGY    
16.28.5    DEVELOPMENTS    
16.29    SYNTHES INC.    
16.29.1    OVERVIEW    
16.29.2    PRODUCTS & SERVICES    
16.29.3    FINANCIALS    
16.29.4    STRATEGY    
16.29.5    DEVELOPMENTS    
16.3    TERUMO MEDICAL CORP    
16.30.1    OVERVIEW    
16.30.2    PRODUCTS & SERVICES    
16.30.3    STRATEGY    
16.30.4    DEVELOPMENTS    
16.31    TOSHIBA    
16.31.1    OVERVIEW    
16.31.2    PRODUCTS & SERVICES    
16.31.3    FINANCIALS    
16.31.4    STRATEGY    
16.31.5    DEVELOPMENTS    
16.32    ZIMMER HOLDINGS    
16.32.1    OVERVIEW    
16.32.2    PRODUCTS & SERVICES    
16.32.3    FINANCIALS    
16.32.4    STRATEGY    
16.32.5    DEVELOPMENTS    


APPENDIX        
    US PATENTS    
    EUROPE PATENTS    
    JAPAN PATENTS   
 
LIST OF TABLES

TABLE 1    GLOBAL TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 2    GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 3    DIAGNOSTIC IMAGING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 4    GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 5    ULTRASOUND MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 6    X-RAY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 7    NUCLEAR IMAGING MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 8    MRI MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 9    COMPUTED TOMOGRAPHY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 10    GLOBAL CARDIOVASCULAR DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 11    CARDIOVASCULAR DEVICES MARKET REVENUE,  BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 12    CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 13    CARDIAC RHYTHM MANAGEMENT DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 14    INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 15    PERIPHERAL VASCULAR DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 16    PROSTHETIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 17    CARDIAC SURGERY DEVICES MARKET REVENUE,  BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 18    ELECTROPHYSIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 19    GLOBAL PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 20    PATIENT MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 21    PATIENT MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 22    VITAL SIGN MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 23    FETAL & NEONATAL MONITORS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 24    ANESTHESIA MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 25    GLOBAL OPHTHALMOLOGY DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 26    OPHTHALMOLOGY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 27    GLOBAL CATARACT DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)    
TABLE 28    CATARACT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 29    INTRAOCULAR LENS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 30    PHACOEMULSIFICATION EQUIPMENT & VISCOELASTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 31    GLOBAL REFRACTIVE ERROR MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)    
TABLE 32    REFRACTIVE ERROR MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 33    GLOBAL REFRACTIVE ERROR DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 34    CONTACT LENS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 35    EXCIMER LASER MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 36    GLOBAL MINIMALLY INVASIVE SURGICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)    
TABLE 37    MINIMALLY INVASIVE SURGICAL DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 38    CARDIOTHORACIC SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 39    ORTHOPEDIC SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 40    GASTROINTESTINAL SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 41    GYNECOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 42    GLOBAL DIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)    
TABLE 43    DIALYSIS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 44    HEMODIALYSIS PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 45    PERITONEAL DIALYSIS PRODUCTS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 46    GLOBAL POC DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 47    POC DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 48    BLOOD GLUCOSE MONITORING MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 49    BLOOD CHEMISTRY & ELECTROLYTE MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 50    PREGNANCY/FERTILITY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 51    CARDIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 52    DRUG OF ABUSE MEASURING DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 53    INFECTIOUS DISEASE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 54    GLOBAL ANESTHESIA & RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 55    ANESTHESIA & RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 56    GLOBAL ANESTHESIA DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)    
TABLE 57    ANESTHESIA DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 58    GLOBAL ANESTHESIA MACHINES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 59    ANESTHESIA MACHINES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 60    GLOBAL ANESTHESIA MONITORS & WORKSTATIONS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 61    ANESTHESIA WORK STATIONS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 62    ANESTHESIA DELIVERY MACHINES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 63    ANESTHESIA VENTILATORS MARKET REVENUE,  BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 64    ANESTHESIA MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 65    GLOBAL ANESTHESIA DISPOSABLES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 66    ANESTHESIA DISPOSABLES MARKET REVENUE,  BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 67    GLOBAL ANESTHESIA DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 68    ENDOTRACHEAL TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 69    ANESTHESIA GAS MASKS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 70    ANESTHESIA BREATHING CIRCUITS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 71    GLOBAL RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 72    RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 73    GLOBAL RESPIRATORY CARE THERAPEUTICS DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 74    RESPIRATORY CARE THERAPEUTICS DEVICES MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 75    RESPIRATORY CARE THERAPEUTICS DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 76    GLOBAL HUMIDIFIERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 77    GLOBAL HUMIDIFIERS MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 78    HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 79    HEATED HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 80    PASSOVER HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 81    NEBULIZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 82    GLOBAL OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 83    GLOBAL OXYGEN CONCENTRATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 84    OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 85    FIXED OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 86    PORTABLE OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 87    GLOBAL PAP DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 88    PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 89    CPAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 90    OTHER PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 91    REUSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 92    GLOBAL VENTILATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 93    GLOBAL VENTILATORS MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 94    VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 95    ADULT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 96    NEONATAL VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 97    GLOBAL RESPIRATORY INHALERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 98    GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 99    RESPIRATORY INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 100    DRY POWDER INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 101    METERED DOSE INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 102    GLOBAL RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 103    RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 104    GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 105    GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 106    RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 107    GLOBAL PULSE OXIMETRY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)    
TABLE 108    PULSE OXIMETRY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 109    PULSE OXIMETER EQUIPMENT MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 110    PULSE OXIMETER SENSORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 111    CAPNOGRAPHS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 112    GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 113    GLOBAL RESPIRATORY DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)    
TABLE 114    GLOBAL RESPIRATORY DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 115    RESPIRATORY DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 116    DISPOSABLE OXYGEN MASK MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 117    DISPOSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 118    TRACHEOSTOMY TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 119    OXYGEN CANNULAE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 120    GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 121    GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET, BY PRODUCTS,  2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 122    RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 123    SPIROMETERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 124    PEAK FLOW METERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 125    POLYSOMNOGRAPHY DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 126    OTHER DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)
TABLE 127    GLOBAL DIABETES CARE DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 128    DIABETES CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 129    GLOBAL GLUCOSE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 130    GLUCOSE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 131    GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)    
TABLE 132    BLOOD GLUCOSE TEST STRIPS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 133    BLOOD GLUCOSE METERS & LANCETS MARKET REVENUE, BY GEOGRAPHY,  2008 – 2015 ($MILLION)    
TABLE 134    INSULIN DELIVERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 135    ORTHOPEDICS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 136    ORTHOPEDICS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 137    ORTHOBIOLOGICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 138    JOINT RECONSTRUCTION MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 139    SPINAL SURGERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 140    TRAUMA FIXATION PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 141    ARTHROSCOPIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 142    ORTHOPEDIC ACCESSORIES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 143    ORTHOPEDIC BRACES & SUPPORTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 144    TOP 10 MEDICAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 145    NORTH AMERICA: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)    
TABLE 146    EUROPE: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 147    ASIA: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS,  2008 – 2015 ($MILLION)
TABLE 148    ROW: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 149    AGREEMENTS & PARTNERSHIPS/CONTRACTS/ALLIANCES
TABLE 150    MERGER, ACQUISITION & COLLABORATION
TABLE 151    PRODUCT LAUNCH/PRODUCT INTEGRATION
TABLE 152    OTHER
TABLE 153    3M COMPANY: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 154    3M COMPANY: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)    
TABLE 155    3M COMPANY: SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 156    ABBOTT LABS: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 157    ABBOTT LABS: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)    
TABLE 158    ABBOTT LABS: SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 159    ALCON: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 160    ALCON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 161    ALCON: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 162    ALLERGAN INC.: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 163    ALLERGAN INC.: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)    
TABLE 164    ALLERGAN INC.: MARKET REVENUE, BY REGION, 2007 – 2009 ($MILLION)
TABLE 165    B. BRAUN: REVENUE AND R&D EXPENSES, 2008 – 2009 ($MILLION)
TABLE 166    B. BRAUN: MARKET REVENUE, BY GEOGRAPHY & BUSINESS SEGMENTS, 2009 ($MILLION)
TABLE 167    BAXTER INTERNATIONAL: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 168    BAXTER INTERNATIONAL: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 169    BAXTER INTERNATIONAL: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)    
TABLE 170    BECKMAN COULTER: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 171    BECKMAN COULTER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 172    BECKMAN COULTER: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 173    BECTON DICKINSON: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 174    BECTON DICKINSON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 175    BECTON DICKINSON: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 176    BIOMET: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 177    BIOMET: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 178    BIOMET: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 179    BOSTON SCIENTIFIC: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 180    BOSTON SCIENTIFIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 181    C.R. BARD: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 182    C.R. BARD: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 183    C.R. BARD: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 184    CARDINAL HEALTH: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)    
TABLE 185    CARDINAL HEALTH: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 186    COVIDIEN: REVENUE AND R&D EXPENSES,  2008 – 2010 ($MILLION)
TABLE 187    COVIDIEN: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 188    COVIDIEN: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 189    DANAHER: REVENUE AND R&D EXPENSES,  2008 – 2010 ($MILLION)
TABLE 190    DANAHER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 191    DANAHER: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 192    DENTSPLY INTERNATIONAL: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)    
TABLE 193    DENTSPLY INTERNATIONAL: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 194    DENTSPLY INTERNATIONAL: MARKET REVENUE, BY REGION, 2007 – 2009 ($MILLION)    
TABLE 195    FRESENIUS MEDICAL CARE: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)    
TABLE 196    FRESENIUS MEDICAL CARE: MARKET REVENUE,  BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 197    FRESENIUS MEDICAL CARE: MARKET REVENUE,  BY GEOGRAPHY, 2007 – 2009 ($MILLION)    
TABLE 198    HITACHI MEDICAL CORP: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 199    HITACHI MEDICAL CORP: MARKET REVENUE,  BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 200    HITACHI MEDICAL CORP: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)    
TABLE 201    HOSPIRA: REVENUE AND R&D EXPENSES,  2007 – 2009 ($MILLION)
TABLE 202    HOSPIRA: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 203    JOHNSON & JOHNSON: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 204    JOHNSON & JOHNSON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 205    JOHNSON & JOHNSON: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)    
TABLE 206    MEDTRONIC: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 207    MEDTRONIC: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)    
TABLE 208    MEDTRONIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 209    OLYMPUS CORP: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 210    OLYMPUS CORP: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)    
TABLE 211    OLYMPUS CORP: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 212    SMITH & NEPHEW: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 213    SMITH & NEPHEW: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)    
TABLE 214    SMITH & NEPHEW: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 215    ST. JUDE MEDICAL INC.: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 216    ST. JUDE MEDICAL INC.: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 217    STRYKER: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 218    STRYKER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 219    STRYKER: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 220    SYNTHES: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 221    SYNTHES: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 222    TOSHIBA: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 223    TOSHIBA: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 224    TOSHIBA: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 225    ZIMMER HOLDINGS: REVENUE AND R&D EXPENSES,  2008 – 2010 ($MILLION)
TABLE 226    ZIMMER HOLDINGS: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)


LIST OF FIGURES

FIGURE 1    GLOBAL TOP 10 MEDICAL DEVICES MARKET, BY SEGMENTS
FIGURE 2    TOP 10 MEDICAL DEVICES MARKET SEGMENTATION
FIGURE 3    MEDICAL DEVICES MARKET SHARE WITH RESPECT TO TOP 30 MARKET PLAYERS (2009)
FIGURE 4    REGIONAL DOMINANCE OF TOP PLAYERS
FIGURE 5    PENETRATION OF TOP MARKET PLAYERS IN  MEDICAL DEVICES INDUSTRY
FIGURE 6    SEGMENT STUDY FOR TOP 10 MEDICAL DEVICES MARKET
FIGURE 7    PATENTS BY SEGMENTS, 2007 – 2011
FIGURE 8    PATENTS BY MARKET PLAYERS, 2007 – 2011
FIGURE 9    GLOBAL DIAGNOSTIC IMAGING DEVICES: MARKET SHARE  OF MAJOR PLAYERS (2009)
FIGURE 10    ULTRASOUND IMAGING APPLICATIONS
FIGURE 11    ULTRASOUND IMAGING MARKET SHARE (2010)
FIGURE 12    MAMMOGRAPHY EQUIPMENT MARKET SHARE (2009)
FIGURE 13    NUCLEAR IMAGING MARKET SHARE (2009)
FIGURE 14    CARDIOVASCULAR DEVICES MARKET SHARE (2009)
FIGURE 15    INTERVENTIONAL CARDIOLOGY MARKET SHARE (2009)
FIGURE 16    ELECTROPHYSIOLOGY MARKET SHARE (2009)
FIGURE 17    CATARACT DEVICES MARKET SHARE (2009)
FIGURE 18    CONTACT LENS COMPANIES MARKET SHARE (2010)
FIGURE 19    MARKET SHARE FOR FIXED OXYGEN CONCENTRATORS
FIGURE 20    MARKET SHARE FOR PORTABLE OXYGEN CONCENTRATORS
FIGURE 21    PULSE OXIMETER MARKET SHARE (2009)
FIGURE 22    ORTHOBIOLOGICS MARKET SHARE (2009)
FIGURE 23    ARTHROSCOPIC DEVICES MARKET SHARE (2009)
FIGURE 24    KEY ORGANIZATIONAL GOALS FOCUSED THROUGH PARTNERSHIP FORMATION
FIGURE 25    MAJOR STRATEGIC FOCUS, BY MARKET PLAYERS, 2009 – 2011
FIGURE 26    MAJOR PLAYERS USING DIFFERENT STRATEGIES TO GROW, 2009 – 2011